After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...
Medical tech company BD (Becton, Dickinson and Co.) acquired MedKeeper, a provider of cloud-based pharmacy management applications, the Franklin Lakes firm announced July 28. The deal – terms of which ...
BD (Becton, Dickinson and Company) has agreed to combine its biosciences and diagnostic solutions business with Waters Corporation, creating a new life science and diagnostics company. The agreement ...
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health (TM) by driving innovation across medical essentials, connected care, biopharma ...
Medical technology company Becton, Dickinson and Company (NYSE:BDX) in Q1 CY2025 as sales rose 4.5% year on year to $5.27 billion. On the other hand, the company’s outlook for the full year was close ...
After nearly a century spent building out its portfolio of insulin pens and syringes, BD is finally ready to let its diabetes care business leave the nest. While reporting financial results for the ...
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE:BDX) announced Monday it has received FDA 510(k) clearance and CE marking in the European Union for its Enteric Bacterial Panel (EBP) ...
BD (Becton, Dickinson and Company) (NYSE:BDX) on Wednesday said Chris DelOrefice, executive vice president and chief financial officer (CFO), will depart the company effective December 5. The company ...
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced that it has selected "embecta" as the name of the independent, publicly-traded company that will hold BD's ...
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE:BDX) announced Tuesday it has commenced tender offers to purchase up to $1.6 billion aggregate purchase price of its outstanding debt ...